NANBING LI-VILLARREAL to Anti-Arrhythmia Agents
This is a "connection" page, showing publications NANBING LI-VILLARREAL has written about Anti-Arrhythmia Agents.
Connection Strength
0.499
-
Treatment of catecholaminergic polymorphic ventricular tachycardia in mice using novel RyR2-modifying drugs. Int J Cardiol. 2017 Jan 15; 227:668-673.
Score: 0.457
-
Cardiac crises: Cardiac arrhythmias and cardiomyopathy during TANGO2 deficiency related metabolic crises. Heart Rhythm. 2022 10; 19(10):1673-1681.
Score: 0.042